ZIMMER BIOMET HOLDINGS, INC. 8-K

What Happened

• Zimmer Biomet Holdings, Inc. announced its quarterly financial results for the quarter ended March 31, 2026 by issuing a press release on April 28, 2026. The company filed an 8-K (dated April 28, 2026) that attaches the press release as Exhibit 99.1 and incorporates that information by reference into the filing. The 8-K was signed by Chad F. Phipps, Senior Vice President, Chief Legal and Corporate Affairs Officer and Secretary.

Key Details

• Filing date: April 28, 2026 (Form 8-K, Items 2.02 and 9.01).
• Period reported: Quarter ended March 31, 2026.
• Disclosure format: Financial results provided via press release attached as Exhibit 99.1 to the 8-K.
• The 8-K itself references the press release for the financial figures (the filing text does not repeat the numerical results).

Why It Matters

• This 8-K signals that Zimmer Biomet has released its latest quarterly earnings and related metrics (revenue, EPS, operating results, and any commentary or guidance likely in the press release). Those results can affect the company’s stock price and investor outlook. Retail investors should review the attached Exhibit 99.1 (or the company’s investor relations page) for the specific revenue, earnings, and guidance details and watch for the subsequent 10-Q for fuller financial statements and disclosures.